Study of Doxorubicin in Patients With Metastatic Breast Cancer/Advanced Ovarian Cancer

NCT03055143 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer and Ovarian Cancer

Interventions

DRUG: SPARC-08-038
DRUG: Ref-08-038

Sponsor

Sun Pharma Advanced Research Company Limited